Dn B Asset Management As Biomarin Pharmaceutical Inc Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
A detailed history of Dn B Asset Management As transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dn B Asset Management As holds 1,021,054 shares of BMRN stock, worth $87.1 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,021,054
Previous 867,187
17.74%
Holding current value
$87.1 Million
Previous $75.7 Million
10.99%
% of portfolio
0.42%
Previous 0.42%
Shares
27 transactions
Others Institutions Holding BMRN
# of Institutions
619Shares Held
182MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.6 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.55 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.24 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.19 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$588 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...